Biodesix (BDSX) Change in Receivables (2019 - 2026)

Biodesix (BDSX) has 8 years of Change in Receivables data on file, last reported at $488000.0 in Q1 2026.

• Quarterly Change in Receivables rose 153.98% year-over-year to $488000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 233.82% YoY) and the FY2025 annual result came in at $531000.0, down 70.68% from the prior year.
• Change in Receivables improved to $488000.0 in Q1 2026, from -$3.6 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $5.2 million in Q3 2025 to a low of -$3.6 million in Q4 2025.
• A 5-year average of $532294.1 and a median of $325000.0 in 2024 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2024 — Change in Receivables soared 7003.03% — and 2025, when it tumbled 460.44%.
• Tracing BDSX's Change in Receivables over 5 years: stood at $736000.0 in 2022, then jumped by 380.98% to $3.5 million in 2023, then slumped by 71.72% to $1.0 million in 2024, then plunged by 460.44% to -$3.6 million in 2025, then surged by 113.53% to $488000.0 in 2026.
• The last three Change in Receivables figures came in at $488000.0 (Q1 2026), -$3.6 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.